Division of Medicinal Chemistry, Leiden Academic Centre for Drug Research (LACDR), Leiden University , P.O. Box 9502, 2300 RA Leiden, The Netherlands.
Chem Rev. 2017 Jan 11;117(1):38-66. doi: 10.1021/acs.chemrev.6b00025. Epub 2016 Apr 18.
Ligand-receptor binding kinetics is an emerging topic in the drug research community. Over the past years, medicinal chemistry approaches from a kinetic perspective have been increasingly applied to G protein-coupled receptors including the adenosine receptors (AR), which are involved in a plethora of physiological and pathological conditions. The study of ligand-AR binding kinetics offers room for detailed structure-kinetics relationships next to more traditional structure-activity relationships. Their combination may facilitate the triage of candidate compounds in hit-to-lead campaigns. Furthermore, kinetic studies also help in understanding AR allosterism. Allosteric modulation may yield a change in the activity and conformation of a receptor resulting from the binding of a compound at a site distinct from where the endogenous agonist adenosine binds. Hence, in this Review, we summarize available data and evidence for the binding kinetics of orthosteric and allosteric AR ligands. We hope this Review will raise awareness to consider the kinetic aspects of drug-target interactions on both ARs and other drug targets.
配体-受体结合动力学是药物研究领域的一个新兴课题。在过去的几年中,从动力学角度出发的药物化学方法已经越来越多地应用于包括腺苷受体(AR)在内的 G 蛋白偶联受体,这些受体涉及到大量的生理和病理状况。配体-AR 结合动力学的研究除了更传统的结构-活性关系之外,还为详细的结构-动力学关系提供了空间。它们的结合可以促进在从命中到先导化合物的研究中对候选化合物进行分类。此外,动力学研究还有助于理解 AR 的变构作用。变构调节可能会导致受体的活性和构象发生变化,这是由于化合物在不同于内源性激动剂腺苷结合的部位结合所致。因此,在这篇综述中,我们总结了关于 AR 的变构和变构配体的正位和变构结合动力学的现有数据和证据。我们希望这篇综述将提高人们对 AR 和其他药物靶点上药物-靶标相互作用的动力学方面的认识。